Risk of Chronic Beryllium Disease by HLA-DPB1 E69 Genotype and Beryllium Exposure in Nuclear Workers

Beryllium sensitization (BeS) and chronic beryllium disease (CBD) are determined by at least one genetic factor, a glutamic acid at position 69 (E69) of the HLA-DPB1 gene, and by exposure to beryllium. The relationship between exposure and the E69 genotype has not been well characterized. The study...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	American journal of respiratory and critical care medicine 2011-06, Vol.183 (12), p.1680-1688
Hauptverfasser:	VAN DYKE, Mike V, MARTYNY, John W, MROZ, Margaret M, SILVEIRA, Lori J, STRAND, Matt, FINGERLIN, Tasha E, SATO, Hiroe, NEWMAN, Lee S, MAIER, Lisa A
Format:	Artikel
Sprache:	eng
Schlagworte:	Adult Aged Aged, 80 and over Alleles Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy Antigens Berylliosis - genetics Beryllium Beryllium - toxicity Biological and medical sciences Chronic Disease Chronic obstructive pulmonary disease, asthma E. Environmental and Occupational Lung Disease Female Genotype Genotype & phenotype Granulomas HLA-DP Antigens - genetics HLA-DP beta-Chains Humans Intensive care medicine Logistic Models Male Medical sciences Middle Aged Nuclear Weapons Occupational Exposure Occupational safety Odds Ratio Pneumology Polymerase Chain Reaction Surveillance Workers
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!